A comparative study to assess two doses of a novel aldose reductase inhibitor (ARI)/Antioxidant drug candidate Cemtirestat, the current ARI drug Epalrestat, and the antioxidant Stobadine on Fructose- and Streptozotocin-Induced hepatic and pancreatic stress responses in rats.
Saved in:
| Title: | A comparative study to assess two doses of a novel aldose reductase inhibitor (ARI)/Antioxidant drug candidate Cemtirestat, the current ARI drug Epalrestat, and the antioxidant Stobadine on Fructose- and Streptozotocin-Induced hepatic and pancreatic stress responses in rats. |
|---|---|
| Authors: | Dagistanli FK; Department of Medical Biology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey., Ceylan AF; Department of Medical Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazıt University, Ankara, Turkey., Elmazoglu Z; Department of Pharmacology, Faculty of Pharmacy, Ankara Medipol University, Ankara, Turkey., Efendiyeva N; Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara, Turkey., Sarıbaş SG; Department of Histology and Embryology, Faculty of Medicine, Health Sciences University Gulhane, Ankara, Turkey., Pilafi BK; Medical University of Tirana, University Dental Clinic, Tiran, Albania., Stefek M; Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovak Republic., Ulusu NN; Department of Biochemistry, School of Medicine, Koç University; Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey., Karasu Ç; Department of Medical Pharmacology, Cellular Stress Response and Signal Transduction Research Laboratory, Faculty of Medicine, Gazi University, Ankara, Turkey. |
| Source: | Journal of diabetes and metabolic disorders [J Diabetes Metab Disord] 2025 Dec 04; Vol. 24 (2), pp. 288. Date of Electronic Publication: 2025 Dec 04 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101590741 Publication Model: eCollection Cited Medium: Print ISSN: 2251-6581 (Print) Linking ISSN: 22516581 NLM ISO Abbreviation: J Diabetes Metab Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
